United States · Series A startup

Who invested in Hinge Bio

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$30Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $30MJan 2025
Investors
1
See who backed them

The rounds

  1. Jan 2025
    Series A$30M

    Source recordedSEC filing: $31M sold, first sale Dec 2024

Founders and team

From Hinge Bio's own website: 2 on the team.

  • Kristen QuigleyChief Clinical Operations Officer
  • Alex SilversteinDirector

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Hinge Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Agent CapitalVC firmPer its own site
Baruch Future VenturesVC firmPer its own site
InVivium CapitalVC firmPer its own site

Quick answers about Hinge Bio

Who invested in Hinge Bio?

Hinge Bio's investors include National Science Foundation.

How much has Hinge Bio raised?

Hinge Bio has raised $30M across 1 round since 2025.

When did Hinge Bio last raise?

Hinge Bio's most recent round was a Series A of $30M in Jan 2025.

What was Hinge Bio's biggest round?

Its most recent round, $30M in Jan 2025, is also its largest on record.

Who backed Hinge Bio first?

Hinge Bio's first round on record, in Jan 2025, was backed by National Science Foundation.

What stage is Hinge Bio at?

Hinge Bio's latest named round is a Series A, in Jan 2025.

Where is Hinge Bio based?

Hinge Bio is based in the United States.

Companies like Hinge Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.